ArticleCancers2020

Multi-Gene Prognostic Signatures and Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in ER-positive, HER2-negative Breast Cancer Patients.

Claudia Mazo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.